Terms: = Ovarian cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Treatment
16 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial ovarian cancer: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(5):1-188. PubMed ID: 37637244
[TBL] [Abstract] [Full Text] [Related]
3. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H; Li B; Zhang X; Meng X
Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
[TBL] [Abstract] [Full Text] [Related]
4. [cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract] [Full Text] [Related]
5. ovarian cancer: sites of recurrence.
Amate P; Huchon C; Dessapt AL; Bensaid C; Medioni J; Le Frère Belda MA; Bats AS; Lécuru FR
Int J Gynecol Cancer; 2013 Nov; 23(9):1590-6. PubMed ID: 24172095
[TBL] [Abstract] [Full Text] [Related]
6. Treating gynecologic malignancies in elderly patients.
Perri T; Katz T; Korach J; Beiner ME; Jakobson-Setton A; Ben-Baruch G
Am J Clin Oncol; 2015 Jun; 38(3):278-82. PubMed ID: 23689643
[TBL] [Abstract] [Full Text] [Related]
7. Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels.
Palomar A; Nanni C; Castellucci P; Ambrosini V; Montini GC; Allegri V; Pettinato C; Al-Nahhas A; Soriano A; Grassetto G; Rubello D; Fanti S
Mol Imaging Biol; 2012 Feb; 14(1):123-9. PubMed ID: 21240639
[TBL] [Abstract] [Full Text] [Related]
8. Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells.
Maiti AK
Pharmacogenomics J; 2010 Apr; 10(2):94-104. PubMed ID: 19918261
[TBL] [Abstract] [Full Text] [Related]
9. Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4.
Tang Z; Bauer JA; Morrison B; Lindner DJ
Mol Cell Biol; 2006 Aug; 26(15):5588-94. PubMed ID: 16847314
[TBL] [Abstract] [Full Text] [Related]
10. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract] [Full Text] [Related]
11. Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity.
Das GC; Bacsi A; Shrivastav M; Hazra TK; Boldogh I
Mol Carcinog; 2006 Sep; 45(9):635-47. PubMed ID: 16491484
[TBL] [Abstract] [Full Text] [Related]
12. Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress.
Boldogh I; Roy G; Lee MS; Bacsi A; Hazra TK; Bhakat KK; Das GC; Mitra S
Toxicology; 2003 Nov; 193(1-2):137-52. PubMed ID: 14599773
[TBL] [Abstract] [Full Text] [Related]
13. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography.
Ueland FR; DePriest PD; Pavlik EJ; Kryscio RJ; van Nagell JR
Gynecol Oncol; 2003 Oct; 91(1):46-50. PubMed ID: 14529661
[TBL] [Abstract] [Full Text] [Related]
14. Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.
Bauer JA; Morrison BH; Grane RW; Jacobs BS; Dabney S; Gamero AM; Carnevale KA; Smith DJ; Drazba J; Seetharam B; Lindner DJ
J Natl Cancer Inst; 2002 Jul; 94(13):1010-9. PubMed ID: 12096086
[TBL] [Abstract] [Full Text] [Related]
15. Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins.
Roy G; Horton JK; Roy R; Denning T; Mitra S; Boldogh I
Oncogene; 2000 Jan; 19(1):141-50. PubMed ID: 10644989
[TBL] [Abstract] [Full Text] [Related]
16. Biochemical and immunological characterization of ectopic tumoral renin.
Soubrier F; Devaux C; Galen FX; Skinner SL; Aurell M; Genest J; Menard J; Corvol P
J Clin Endocrinol Metab; 1982 Jan; 54(1):139-44. PubMed ID: 7033266
[TBL] [Abstract] [Full Text] [Related]
